Pharmacogenomics improves quality of healthcare and saves thousands on health benefit plans. Hear from Brad Tice, Founder and CEO of RxGenomix in our latest marketplace webinar.
Brad Tice, PharmD, MBA, FAPhA is the Founder and CEO of RxGenomix. His career has spanned the pharmacy spectrum working with independent, chain and hospital pharmacies through Cardinal Health, Humana, entrepreneurial start-ups, community pharmacy and academia.
Watch the full webinar to learn more about pharmacogenomics and how a person’s genes affect how they respond to medications. This research is a long-term solution that will help control the cost of healthcare and the severity of claims made.
Brad Tice,
Founder & CEO of RxGenomix
A full 50% of medications may not be right for any one individual, all due to their unique genetic profile. That means a medication that may be beneficial or even life-saving for one person could be ineffective or dangerous for another. Getting that one thing right could make a life-changing difference in how long it takes someone to get effective treatment, how many trips to the doctor or hospital it’s going to take, and their quality of life along the way.
The partnership between RxGenomix and NavMD began from a collaborative passion to address the rising costs of healthcare, overprescribing of medication, and ultimately, to improve the standard of healthcare to find the right medication on the first try.
Have a tool on your side that is proven to drive results for any size, any plan.
You’re a health benefits expert; spend less time cleaning and normalizing health plan data and more time advising on solutions that create value.
Spend more time face to face with your clients, delivering solutions that make you stand out in the market.
